Ivy Rx Review

Ivy Rx: a flat-rate compounded GLP-1 shop with a simple promise

Ivy Rx is a no-frills telehealth provider built around one idea that most patients actually care about: you pay the same price no matter how high your dose climbs. Where a lot of GLP-1 programs quietly raise your bill every time your prescriber bumps your milligrams, Ivy Rx markets a flat rate, promising "same price, every dose, no surprises, no insurance needed." That's the pitch. If you found GLP-1 medication confusing or you got burned by a program that escalated costs as you titrated up, Ivy Rx is worth a look. Just go in knowing it publishes relatively little about its operation, which is the main reason to keep your expectations measured.

How the flat pricing really works

Ivy Rx runs two straightforward programs. Compounded semaglutide starts at $175 a month, and compounded tirzepatide starts higher, in the high-two-hundreds. The word "starting" matters: the published ranges drift up modestly from there (semaglutide into the high-one-nineties, tirzepatide into the high-two-nineties), so the flat-rate promise is best understood as a tight band rather than a single frozen number. The important part is that the band is driven by which medication you're on, not by how far you titrate. Once you're on semaglutide, going from a low maintenance dose to a higher one shouldn't change your monthly cost the way it does at dose-tiered competitors.

For context, Ivy Rx's entry semaglutide price sits a touch above the category median of $169 a month — so it isn't the rock-bottom cheapest option, but it's firmly in mainstream territory and undercuts the thousand-dollar-plus list prices of brand-name injectables by a wide margin.

What's bundled into the price

• The medication itself
• The medical consultation and prescriber approval
• Shipping to your door, advertised as fast and free

That bundle matters because some "cheap" programs tack on a separate consult fee or charge for shipping. Ivy Rx folds all three into the monthly number, so the price you see is closer to the price you actually pay. There's no membership add-on stacked on top.

The medications and how you get them

Both of Ivy Rx's drugs are compounded — not the brand-name Wegovy, Ozempic, Zepbound, or Mounjaro you'd get at a retail pharmacy, but versions of the same active ingredients (semaglutide and tirzepatide) made by a compounding pharmacy. Compounded GLP-1s are typically less expensive and have been a workaround during brand shortages, but they aren't FDA-approved products and quality hinges entirely on the pharmacy behind them. Ivy Rx advertises a free consultation with fast approval and quick delivery, which points to a streamlined, asynchronous online intake rather than a high-touch clinical relationship.

What sets Ivy Rx apart — and what's missing

The genuine differentiator here is dose-independent pricing on two of the most-wanted GLP-1 molecules at once. Plenty of providers carry semaglutide; fewer pair it with tirzepatide and then commit to not punishing you for titrating up. If predictable monthly budgeting is your priority, that's a real selling point.

The honest flip side is transparency. Ivy Rx publishes limited detail about the nuts and bolts of its program. Ivy Rx doesn't say which compounding pharmacy fills its prescriptions, what accreditation that pharmacy holds, or what its concrete policies are on refunds, dose changes, side-effect support, or pausing treatment. It lists availability as all fifty states; confirm yours at sign-up. None of that is a red flag on its own. It's simply unpublished, and for a medication you inject weekly, unpublished is a fair reason to ask questions before you pay.

Who should choose Ivy Rx — and who should skip it

• Good fit: budget-minded patients who want a predictable, flat monthly cost as they titrate, and who are comfortable with compounded medication and a low-touch online process
• Good fit: people who want both semaglutide and tirzepatide available from one provider without dose-based price creep
• Skip it if: you want brand-name Wegovy or Zepbound — Ivy Rx only offers compounded formulations
• Skip it if: you need hands-on clinical support, detailed published policies, or a named, accredited pharmacy you can vet before committing

Trust, safety, and medical oversight

On the reassuring side, Ivy Rx has no FDA warning letters on file, and its programs include a prescriber consultation rather than selling medication with no clinical gate. On the cautious side, the picture is limited by how little the provider discloses: with no identified compounding partner and no published accreditation, you're taking the support model partly on faith. The pragmatic move is to confirm the pharmacy's name and accreditation, the current exact price for your specific drug, and the refund and dose-change terms directly with Ivy Rx before your first order. You can see how we weigh these factors in our scoring methodology.

The bottom line

Ivy Rx is a clean, mainstream way to get compounded semaglutide or tirzepatide at a flat rate that won't balloon as your dose rises, with the consult and shipping baked in. That predictability is its strongest card. The catch is thin public information — so it earns a qualified recommendation for cost-conscious patients who are comfortable doing a little homework on the phone before they buy, rather than for anyone who needs everything spelled out and accredited up front.

For a side-by-side, Enhance MD ($169/month) and DudeMeds ($175/month) are the most comparable options to weigh against Ivy Rx.